CDTX - Cidara Therapeutics EPS beats by $0.18 beats on revenue November, 07 2019 10:52 PM Cidara Therapeutics Inc. Cidara Therapeutics (NASDAQ:CDTX): Q3 GAAP EPS of -$0.08 beats by $0.18.Revenue of $19.1M beats by $13.1M.Press ReleaseMore news on: Cidara Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,